DUAL INHIBITION OF ERK 1 / 2 AND AKT PATHWAYS IS REQUIRED TO SUPPRESS THE 1 GROWTH AND SURVIVAL OF ENDOMETRIOTIC CELLS AND LESIONS 2 3